Wyeth Pharmaceuticals and Solvay Pharmaceuticals, Inc. Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigation
COLLEGEVILLE, Pa., Aug. 10 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Solvay Pharmaceuticals, Inc. announced...